There are a few studies evaluating the predictive value of Framingham risk score (FRS) for cardiovascular disease (CVD) risk assessment in patients with metabolic syndrome in Iran. Because of the emerging high prevalence of CVD among Iranian population, it is important to predict its risk among ...
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439-2454. doi:10.1093/eurheartj/ehab309 PubMedGoogle ScholarCrossref 23. Klijs B, Scholtens S, Mandemakers JJ, Snieder H...
The aim of this study was to determine the association between carotid intima-media thickness (IMT) and newly developed 10-year atherosclerotic cardiovascular disease (ASCVD) risk score. Participants were 201 Korean adults who underwent carotid ultrasonography at the Health Promotion Center of the Eulj...
Cardiovascular diseaseRisk scoringCoronary artery calciumRisk factors related to the development of subclinical atherosclerosis and subsequent cardiovascular disease (CVD) events are well established. Starting with the Framingham Risk Score (FRS), several algorithms have been developed using these risk factors...
Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score doi:10.1093/eurheartjsupp/suae100Atherosclerotic cardiovascular diseaseCardiovascular risk calculator10-Year risk of fatal and non-fatal CVD eventsLifetime riskResidual riskCardiovascular diseases (CVDs) remain a ...
Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models HIV Me...
The accuracy of various 10-year cardiovascular disease (CVD) risk calculators in Indians may not be the same as in other populations. Present study was conducted to compare the various calculators for CVD risk assessment and statin eligibility according to different guidelines. Methods Consecutive 1110...
(SCORE2-Diabetes) specific for patients with T2D without atherosclerotic cardiovascular disease (ASCVD) or severe target-organ damage (TOD). On the other hand, patients with T2D and ASCVD are recommended to initiate treatment with GLP-1 RAs and SGLT2is to reduce CV risk, independent of glucose...
We investigated cardiovascular disease (CVD) risk factors in 1501 Greeks (613 men and 888 women, aged 40-65 years) referred to outpatients with metabolic syndrome (MetS) and without diabetes mellitus or CVD. The 10-year risk of fatal CVD events was calculated using European Society of Cardiolog...
In this model revision initiative, we derived 10-year risk prediction models for fatal and non-fatal cardiovascular disease (ie, myocardial infarction and stroke) using individual participant data from the Emerging Risk Factors Collaboration. Models included information on age, smoking status, systolic...